Literature DB >> 2994553

Cytomegalovirus and herpes simplex virus ascending myelitis in a patient with acquired immune deficiency syndrome.

T Tucker, R D Dix, C Katzen, R L Davis, J W Schmidley.   

Abstract

Progressive ascending myelitis was the presenting feature of the acquired immune deficiency syndrome (AIDS) in a homosexual man who also had Kaposi's sarcoma, Pneumocystis pneumonia, and disseminated cytomegalovirus (CMV) infection. Neuropathological studies showed profuse cytomegalic cells throughout the brain and spinal cord, but no inflammatory response. At postmortem examination, CMV and herpes simplex virus, type 2 (HSV-2), were recovered from multiple sites throughout the central nervous system (CNS). HSV-2 was isolated from the anus, but from no other extraneural site; in contrast, pathology typical of CMV was also seen in the liver, gastrointestinal tract, adrenals, and lungs. Although histopathological evidence suggesting prior CMV infection has been seen in the brains of AIDS patients, the virus has never been cultured from the CNS in these immunosuppressed hosts, nor has it been known to infect the spinal cord. The absence of an inflammatory response suggests that the pathogenesis of CNS viral infections is altered in AIDS patients. Evidence for CMV infection of the CNS in AIDS patients is no longer circumstantial.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2994553     DOI: 10.1002/ana.410180113

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  22 in total

Review 1.  Diagnosis of cytomegalovirus infection: a review.

Authors:  D Pillay; P D Griffiths
Journal:  Genitourin Med       Date:  1992-06

Review 2.  Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: Case report and review of the literature.

Authors:  Aaron Haug; Ravi Mahalingam; Randall J Cohrs; D Scott Schmid; John R Corboy; Don Gilden
Journal:  J Neurol Sci       Date:  2010-02-19       Impact factor: 3.181

3.  Acute lumbosacral polyradiculopathy due to cytomegalovirus in advanced HIV disease: CSF findings in 17 patients.

Authors:  R F Miller; J D Fox; P Thomas; J C Waite; Y Sharvell; B G Gazzard; M J Harrison; N S Brink
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

4.  Ischaemic myelopathy secondary to disseminated intravascular coagulation in AIDS.

Authors:  G Fenelon; F Gray; F Scaravilli; F Mahieux; R Gherardi; P Chemouilli; A Guillard
Journal:  J Neurol       Date:  1991-02       Impact factor: 4.849

5.  Acute myeloradiculitis due to cytomegalovirus as the initial manifestation of AIDS.

Authors:  F Mahieux; F Gray; G Fenelon; R Gherardi; D Adams; A Guillard; J Poirier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

Review 6.  The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Cinque; G M Cleator; T Weber; P Monteyne; C J Sindic; A M van Loon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

7.  Myelography in patients with acquired immuno deficiency syndrome. Indications and results.

Authors:  B J Borgstein; P A Koster; P Portegies; F L Peeters
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

8.  Concurrent herpes simplex type 1 necrotizing encephalitis, cytomegalovirus ventriculoencephalitis and cerebral lymphoma in an AIDS patient.

Authors:  C Vital; E Monlun; A Vital; M L Martin-Negrier; V Cales; F Leger; M Longy-Boursier; M Le Bras; B Bloch
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 9.  Neurologic and psychiatric manifestations of HIV disease.

Authors:  H Hollander
Journal:  J Gen Intern Med       Date:  1991 Jan-Feb       Impact factor: 5.128

Review 10.  Neurological complications in AIDS.

Authors:  P A Fischer; W Enzensberger
Journal:  J Neurol       Date:  1987-06       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.